Wockhardt recalls hypertension drug in US

Wockhardt recalls hypertension drug in US

FPJ BureauUpdated: Saturday, June 01, 2019, 12:50 PM IST
article-image

Hyderabad:  Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said.  According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification.             The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.

RECENT STORIES

Mahindra & Mahindra Opens Doors, Offering Internal Combustion Engine-Powered SUVs & Electric...

Mahindra & Mahindra Opens Doors, Offering Internal Combustion Engine-Powered SUVs & Electric...

'Starlink Ready For India, Will Provide Low-Cost, Reliable Internet, Especially In Rural Areas':...

'Starlink Ready For India, Will Provide Low-Cost, Reliable Internet, Especially In Rural Areas':...

Lodha Developers To Launch ₹14k Cr Worth Housing Projects In 2nd Half Of FY26

Lodha Developers To Launch ₹14k Cr Worth Housing Projects In 2nd Half Of FY26

Gold Could Retest Record Highs As Traders Eye Powell's Speech, RBI Policy: Analysts

Gold Could Retest Record Highs As Traders Eye Powell's Speech, RBI Policy: Analysts

Udyogini Yojana: A Big Opportunity For Women Entrepreneurs, Find Out How You Can Get A Loan Up to...

Udyogini Yojana: A Big Opportunity For Women Entrepreneurs, Find Out How You Can Get A Loan Up to...